BioCentury
ARTICLE | Company News

Inviragen, PharmaJet, National Institutes of Health infectious, drug delivery news

October 18, 2010 7:00 AM UTC

The companies received a five-year, $15.5 million contract from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to develop a needle-free dengue vaccine. The companies are developin...